Eric Joseph
Stock Analyst at Citi
(4.47)
# 1,059
Out of 4,386 analysts
323
Total ratings
51.9%
Success rate
11.4%
Average return
Main Sectors:
Stocks Rated by Eric Joseph
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBIO BridgeBio Pharma | Maintained: Hold | $82 | $67.37 | +21.72% | 3 | Jun 1, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Buy | $80 | $56.55 | +41.47% | 4 | May 20, 2026 | |
| IONS Ionis Pharmaceuticals | Initiated Coverage: Buy | $115 → $90 | $73.54 | +22.38% | 2 | May 20, 2026 | |
| ALNY Alnylam Pharmaceuticals | Initiated Coverage: Buy | $380 | $292.16 | +30.07% | 1 | May 19, 2026 | |
| CYTK Cytokinetics | Initiated Coverage: Buy | $99 | $67.90 | +45.80% | 1 | May 19, 2026 | |
| ASND Ascendis Pharma | Initiated Coverage: Buy | $355 | $205.81 | +72.49% | 1 | May 15, 2026 | |
| TGTX TG Therapeutics | Maintained: Buy | $46 → $49 | $40.95 | +19.66% | 18 | Nov 3, 2025 | |
| PLRX Pliant Therapeutics | Downgraded: Sell | n/a | $1.16 | - | 7 | Oct 10, 2025 | |
| BEAM Beam Therapeutics | Reiterated: Buy | $48 | $29.78 | +61.18% | 20 | Jun 25, 2025 | |
| KYMR Kymera Therapeutics | Reiterated: Buy | $57 → $64 | $73.95 | n/a | 11 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $67 | $70.87 | n/a | 30 | May 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $44 → $7 | $2.70 | n/a | 20 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $7 | $8.62 | n/a | 23 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.96 | n/a | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $18 | $4.09 | n/a | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $30.41 | n/a | 3 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $11 | $13.66 | n/a | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 | $8.45 | n/a | 14 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $1.43 | n/a | 1 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $12 | $17.00 | n/a | 10 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $21 | $5.70 | n/a | 5 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $71 → $70 | $148.49 | n/a | 18 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $9 → $5 | $11.07 | n/a | 13 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $30 | $15.64 | n/a | 11 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 | $1.15 | n/a | 11 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $7 | $3.59 | n/a | 6 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 → $10 | $3.32 | n/a | 6 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $5 | $12.31 | n/a | 2 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $28 → $5 | $2.12 | n/a | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $4.32 | n/a | 12 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $5 | $1.46 | n/a | 4 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $20.69 | n/a | 2 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $5 | $8.50 | n/a | 8 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $13 | $3.29 | n/a | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $5 | $4.96 | n/a | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $7 | $1.85 | n/a | 6 | Mar 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $0.9356 | n/a | 5 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $11 | $6.77 | n/a | 3 | Nov 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $9.85 | n/a | 2 | Oct 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $0.0001 | n/a | 3 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $39 → $26 | $27.25 | n/a | 3 | Sep 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.57 | n/a | 1 | Feb 7, 2020 |
BridgeBio Pharma
Jun 1, 2026
Maintained: Hold
Price Target: $82
Current: $67.37
Upside: +21.72%
BioMarin Pharmaceutical
May 20, 2026
Maintained: Buy
Price Target: $80
Current: $56.55
Upside: +41.47%
Ionis Pharmaceuticals
May 20, 2026
Initiated Coverage: Buy
Price Target: $115 → $90
Current: $73.54
Upside: +22.38%
Alnylam Pharmaceuticals
May 19, 2026
Initiated Coverage: Buy
Price Target: $380
Current: $292.16
Upside: +30.07%
Cytokinetics
May 19, 2026
Initiated Coverage: Buy
Price Target: $99
Current: $67.90
Upside: +45.80%
Ascendis Pharma
May 15, 2026
Initiated Coverage: Buy
Price Target: $355
Current: $205.81
Upside: +72.49%
TG Therapeutics
Nov 3, 2025
Maintained: Buy
Price Target: $46 → $49
Current: $40.95
Upside: +19.66%
Pliant Therapeutics
Oct 10, 2025
Downgraded: Sell
Price Target: n/a
Current: $1.16
Upside: -
Beam Therapeutics
Jun 25, 2025
Reiterated: Buy
Price Target: $48
Current: $29.78
Upside: +61.18%
Kymera Therapeutics
Jun 2, 2025
Reiterated: Buy
Price Target: $57 → $64
Current: $73.95
Upside: n/a
May 30, 2025
Reiterated: Buy
Price Target: $67
Current: $70.87
Upside: n/a
May 28, 2025
Downgraded: Hold
Price Target: $44 → $7
Current: $2.70
Upside: n/a
May 19, 2025
Reiterated: Sell
Price Target: $7
Current: $8.62
Upside: n/a
May 19, 2025
Downgraded: Hold
Price Target: n/a
Current: $2.96
Upside: n/a
May 16, 2025
Maintained: Buy
Price Target: $22 → $18
Current: $4.09
Upside: n/a
May 14, 2025
Maintained: Buy
Price Target: n/a
Current: $30.41
Upside: n/a
May 13, 2025
Maintained: Buy
Price Target: $21 → $11
Current: $13.66
Upside: n/a
May 7, 2025
Maintained: Hold
Price Target: $14
Current: $8.45
Upside: n/a
Apr 25, 2025
Initiated Coverage: Hold
Price Target: n/a
Current: $1.43
Upside: n/a
Mar 20, 2025
Maintained: Buy
Price Target: $15 → $12
Current: $17.00
Upside: n/a
Mar 4, 2025
Maintained: Buy
Price Target: $20 → $21
Current: $5.70
Upside: n/a
Feb 27, 2025
Maintained: Buy
Price Target: $71 → $70
Current: $148.49
Upside: n/a
Feb 10, 2025
Maintained: Sell
Price Target: $9 → $5
Current: $11.07
Upside: n/a
Jan 29, 2025
Maintained: Buy
Price Target: $31 → $30
Current: $15.64
Upside: n/a
Dec 17, 2024
Reiterated: Hold
Price Target: $11
Current: $1.15
Upside: n/a
Feb 23, 2024
Maintained: Hold
Price Target: $6 → $7
Current: $3.59
Upside: n/a
Nov 13, 2023
Maintained: Hold
Price Target: $11 → $10
Current: $3.32
Upside: n/a
Aug 28, 2023
Downgraded: Hold
Price Target: $15 → $5
Current: $12.31
Upside: n/a
Aug 28, 2023
Downgraded: Hold
Price Target: $28 → $5
Current: $2.12
Upside: n/a
Aug 10, 2023
Downgraded: Sell
Price Target: n/a
Current: $4.32
Upside: n/a
May 5, 2023
Maintained: Hold
Price Target: $6 → $5
Current: $1.46
Upside: n/a
Nov 29, 2022
Downgraded: Sell
Price Target: n/a
Current: $20.69
Upside: n/a
Nov 4, 2022
Maintained: Hold
Price Target: $6 → $5
Current: $8.50
Upside: n/a
May 5, 2022
Maintained: Hold
Price Target: $12 → $13
Current: $3.29
Upside: n/a
May 5, 2022
Maintained: Hold
Price Target: $6 → $5
Current: $4.96
Upside: n/a
Mar 29, 2022
Maintained: Buy
Price Target: $24 → $7
Current: $1.85
Upside: n/a
Mar 4, 2022
Maintained: Sell
Price Target: n/a
Current: $0.9356
Upside: n/a
Nov 11, 2021
Maintained: Hold
Price Target: $14 → $11
Current: $6.77
Upside: n/a
Oct 8, 2021
Downgraded: Sell
Price Target: n/a
Current: $9.85
Upside: n/a
Nov 9, 2020
Downgraded: Sell
Price Target: n/a
Current: $0.0001
Upside: n/a
Sep 21, 2020
Maintained: Hold
Price Target: $39 → $26
Current: $27.25
Upside: n/a
Feb 7, 2020
Reiterated: Hold
Price Target: n/a
Current: $3.57
Upside: n/a